These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17828397)

  • 1. Modulation of glomerulosclerosis.
    Ma LJ; Fogo AB
    Semin Immunopathol; 2007 Nov; 29(4):385-95. PubMed ID: 17828397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of disease reversal in focal and segmental glomerulosclerosis.
    Yang HC; Fogo AB
    Adv Chronic Kidney Dis; 2014 Sep; 21(5):442-7. PubMed ID: 25168834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesangial matrix modulation and glomerulosclerosis.
    Fogo AB
    Exp Nephrol; 1999; 7(2):147-59. PubMed ID: 10213868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary focal segmental glomerulosclerosis is associated with increased intraglomerular type IV collagen synthesis.
    Razzaque MS; Koji T; Harada T; Nakane PK; Taguchi T
    Clin Chim Acta; 1995 Feb; 235(1):121-4. PubMed ID: 7634489
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular basis of injury and progression in focal glomerulosclerosis.
    Harris RC
    Nephron; 1999; 82(4):289-99. PubMed ID: 10450030
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential expression of glomerular extracellular matrix and growth factor mRNA in rapid and slowly progressive glomerulosclerosis: studies in mice transgenic for native or mutated growth hormone.
    Yang CW; Striker GE; Chen WY; Kopchick JJ; Striker LJ
    Lab Invest; 1997 Apr; 76(4):467-76. PubMed ID: 9111509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagen and collagenase mRNAs in normal and sclerotic glomeruli: predictors of progression and response to therapy.
    He CJ; Yang CW; Peten EP; Liu ZH; Patel A; Striker LJ; Striker GE
    Kidney Int Suppl; 1995 Jun; 49():S39-43. PubMed ID: 7674591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1.
    Ma LJ; Nakamura S; Aldigier JC; Rossini M; Yang H; Liang X; Nakamura I; Marcantoni C; Fogo AB
    J Am Soc Nephrol; 2005 Apr; 16(4):966-76. PubMed ID: 15728787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular cell proteoglycans: their possible role in progressive glomerular disease.
    Davies M
    Exp Nephrol; 1995; 3(2):122-6. PubMed ID: 7773631
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo transfection of genes for renin and angiotensinogen into the glomerular cells induced phenotypic change of the mesangial cells and glomerular sclerosis.
    Arai M; Wada A; Isaka Y; Akagi Y; Sugiura T; Miyazaki M; Moriyama T; Kaneda Y; Naruse K; Naruse M
    Biochem Biophys Res Commun; 1995 Jan; 206(2):525-32. PubMed ID: 7826369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen turnover in renal disease.
    Costigan M; Chambers DA; Boot-Handford RP
    Exp Nephrol; 1995; 3(2):114-21. PubMed ID: 7773630
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of matrix synthesis, remodeling and accumulation in glomerulosclerosis.
    Pozzi A; Voziyan PA; Hudson BG; Zent R
    Curr Pharm Des; 2009; 15(12):1318-33. PubMed ID: 19355971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. apoE expression in glomerulus and correlation with glomerulosclerosis induced by adriamycin in rats.
    Zhou TB; Qin YH; Lei FY; Su LN; Zhao YJ; Huang WF
    Ren Fail; 2011; 33(3):348-54. PubMed ID: 21401362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Less gelatinases is associated with apolipoprotein E accumulation in glomerulosclerosis rats.
    Zhou TB; Qin YH; Lei FY; Su LN; Zhao YJ; Huang WF
    Histol Histopathol; 2012 Feb; 27(2):249-56. PubMed ID: 22207560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of glomerulosclerosis: current concepts.
    Striker GE
    Nihon Jinzo Gakkai Shi; 1991 May; 33(5):447-9. PubMed ID: 1895545
    [No Abstract]   [Full Text] [Related]  

  • 16. Intraglomerular lipid deposition in experimental focal glomerular sclerosis in the rat.
    Ohsawa H; Yamabe H; Ozawa K; Fukushi K; Kubota H; Chiba N; Sohma Y; Kanazawa T; Onodera K
    Nephron; 1988; 50(1):66. PubMed ID: 3173607
    [No Abstract]   [Full Text] [Related]  

  • 17. Advanced glomerulosclerosis is reversible in nephrotic mice.
    Mizuno-Horikawa Y; Mizuno S; Tamura S; Kurosawa T
    Biochem Biophys Res Commun; 2001 Jun; 284(3):707-13. PubMed ID: 11396960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathy.
    Morita M; Mii A; Shimizu A; Yasuda F; Shoji J; Masuda Y; Ohashi R; Nagahama K; Kaneko T; Tsuruoka S
    PLoS One; 2015; 10(4):e0116700. PubMed ID: 25875837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal fibrosis and the renin-angiotensin system.
    Fogo AB
    Adv Nephrol Necker Hosp; 2001; 31():69-87. PubMed ID: 11692472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rab 23 is expressed in the glomerulus and plays a role in the development of focal segmental glomerulosclerosis.
    Huang TH; Shui HA; Ka SM; Tang BL; Chao TK; Chen JS; Lin YF; Chen A
    Nephrol Dial Transplant; 2009 Mar; 24(3):743-54. PubMed ID: 18927122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.